Affordable Insulin Now Act

Hozzl · 2025-01-04T11:12:26Z

Explore the details of House Bill 1488 Affordable Insulin Now Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

1/4/2025, 11:12 AM

Summary of Bill HR 1488

The Affordable Insulin Now Act, also known as Bill 118 hr 1488, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to make insulin more affordable and accessible to those who need it.

The bill proposes several measures to achieve this goal. Firstly, it aims to cap the out-of-pocket costs for insulin at $35 per month for those with private insurance. This would help to alleviate the financial burden that many individuals with diabetes face when trying to afford their medication.

Additionally, the bill seeks to increase transparency in the pricing of insulin by requiring manufacturers to justify any price increases. This would help to hold pharmaceutical companies accountable for their pricing practices and prevent them from unfairly raising the cost of insulin. Furthermore, the Affordable Insulin Now Act includes provisions to expand access to affordable insulin for individuals who are uninsured or underinsured. This could include creating a program to provide insulin at a reduced cost or for free to those who qualify based on income level. Overall, the Affordable Insulin Now Act is aimed at addressing the rising cost of insulin and ensuring that individuals with diabetes can afford the medication they need to manage their condition. By capping out-of-pocket costs, increasing transparency in pricing, and expanding access to affordable insulin, this bill has the potential to make a significant impact on the lives of those who rely on this life-saving medication.

Congressional Summary of HR 1488

Affordable Insulin Now Act

This bill limits cost-sharing for insulin under private health insurance.

Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 1488

Bill HR 1488 is currently in the status of Bill Introduced since March 9, 2023. Bill HR 1488 was introduced during Congress 118 and was introduced to the House on March 9, 2023. Bill HR 1488's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 1488

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

182

Democrat Cosponsors

182

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 1488

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 1488

Affordable Insulin Now ActAffordable Insulin Now ActTo amend title XXVII of the Public Health Service Act, the Internal Revenue Code of 1986, and the Employee Retirement Income Security Act of 1974 to establish requirements with respect to cost-sharing for certain insulin products, and for other purposes.

Start holding our government accountable!